In Vitro Diagnostics | Market Insights | US | 2021
While the COVID-19 pandemic will have a negative impact on the US IVD market in the near term, the market will nonetheless exhibit moderate growth over the forecast period, driven by the aging US population and the shift toward value-based health care, which will fuel uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IVDs in the US across a 10-year period.